Dopamine reuptake site densities in patients with social phobia

American Journal of Psychiatry

Volumn 154, Issue 2, 1997, Pages 239-242

  Tiihonen, Jari ^a   Kuikka, Jyrki ^b   Bergström, Kim ^b   Lepola, Ulla ^b   Koponen, Hannu ^b   Leinonen, Esa ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL PHOBIA; WHITE MATTER;

EID: 0031018537     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.2.239     Document Type: Article

References (29)

1. Myers JK, Weissman MM, Tischler GL, Holzer CE III, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr, Kramer M, Stoltzman R: Six-month prevalence of psychiatric disorders in three communities: 1980 to 1982. Arch Gen Psychiatry 1984; 41:959-967
2. Stein MB, Walker JR, Forde DR: Setting diagnostic thresholds for social phobia: considerations from a community study of social anxiety. Am J Psychiatry 1994; 152:408-412
3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19
4. Davidson JRT, Hughes DC, George LK, Blazer DG: The boundary of social phobia. Arch Gen Psychiatry 1994; 51:975-983
5. Uhde TW, Tancer ME, Black B, Brown TM: Phenomenology and neurobiology of social phobia: comparison with panic disorder. J Clin Psychiatry 1991; 52(Nov suppl):31-40
6. Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A: Phenelzine in social phobia. J Clin Psychopharmacol 1986; 6:93-98
7. Versiani M, Mundim FD, Nardi AE, Liebowitz MR: Tranylcypromine in social phobia. J Clin Psychopharmacol 1988; 8:279-283
8. Liebowitz MR, Gorman JM, Fyer AJ, Campeas R, Levin AP, Sand- berg D, Hollander E, Papp L, Goetz D: Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol. J Clin Psychiatry 1988; 49:252-257
9. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R: Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992; 161:353-360
10. Mikkelsen EJ, Deltor J, Cohen DJ: School avoidance and social phobia triggered by haloperidol in patients with Tourette's syndrome. Am J Psychiatry 1981; 138:1572-1576
11. Ports NLS, Davidson JRT: Social phobia: biological aspects and pharmacotherapy. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16:635-646
12. Cloninger CR (ed): The Temperament and Character Inventory (TCI): A Guide to its Development and Use. St Louis, Center for Psychobiology of Personality, 1994
13. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genet 1996; 12:78-80
14. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH: Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet 1996; 12:81-84
15. Uhl GR: Neurotransmitter transporters (plus): a promising new gene family. Trends Neurosci 1992; 15:265-268
16. 123I]β-CIT) in human brain. Eur J Nucl Med 1993; 20:783-786
17. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16:93-103
18. 123I]β-CIT: binding kinetics in the human brain. J Neural Transm 1993; 94:137-146
19. Innis R, Seibyl J, Scanley BE, Laruelle M, Abi-Dargham A, Wal- lace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, Charney D, Gao Y, Neumeyer J, Marek K, Hoffer P: Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci USA 1993; 90:11965-11969
20. Kuikka JT, Bergström KA, Ahonen A, Länsimies E: The dosimetry of iodine-123-labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane. Eur J Nucl Med 1994; 21:53-56
21. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiiliäinen H: Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Commun 1993; 14:490-497
22. 123I]β.CIT, a tracer for dopamine and serotonin reuptake sites: preparation and preliminary SPECT studies in humans. J Nucl Biol Med 1994; 38(4, suppl 1):128-131
23. Kuikka JT, Tiihonen J, Bergström KA, Karhu J, Hartikainen P, Viinamäki H, Länsimies E, Lehtonen J, Hakola P: Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 1995; 22:346-350
24. Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen O-P, Föhr J: Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1:654-657
25. 123I]β-CIT SPECT. Parkinsonism and Related Disorders 1995; 1:47-51
26. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp 217-222
27. Bandecchi A: An ethological model of long-term modification of dimensions of the temperament (abstract). Neuropsychopharmacology 1994; 10:725S
28. 11C]raclopride. J Cereb Blood Flow Metab 1993; 13:310-314
29. Sutherland T, Cohen RM, Molchan S, Lawlor BA, Mellow AM, Newhouse PA, Tariot PN, Mueller EA, Murphy DL: High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994; 51:607-615